CURIA GLOBAL INC
- ALBANY, NY 12203-5154
- curiaglobal.com (company website, opens in a new tab)
- Corporate Entity (Not Tax Exempt)
- SAM active
- No verified credentials yet
- CMMCNot on file
- SPRSNone
- FCLVisible to paid members
Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works
- 36-mo obligations
- $9.2M
- Awards on record
- 17
- Contract vehicles
- 0
- Verified credentials
- 0
Compliance posture: unverified (SAM.gov baseline only)
CURIA GLOBAL INC has not claimed this profile. What you see comes from public SAM.gov and USAspending records; no one from the company has confirmed CMMC, SPRS or clearance details yet. Learn more about CMMC 2.0
About CURIA GLOBAL INC
- Headquarters
- ALBANY, NY 12203-5154
Identifiers
UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.
- UEIELCNZCS8GEA3
- CAGE3D1R9
Capabilities & differentiators
No capability narrative yet
Compliance posture
No compliance posture published yet
Facility clearance
Facility clearance: visible to paid members
Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans
Past performance
- 36-month obligations
- $9.2M
- Awards on record
- 17
- Top funding agencies
- National Institutes of Health · Department of Veterans Affairs
Awards
75N95024P00615
Recompete 6–12 mo: Potential end Sep 18, 2027 (10 months away)NON-GMP SYNTHESIS OF COMPOUNDS. POP: 9/19/24-9/18/25.
Department of Health and Human Services · National Institutes of Health
- Obligated
- $884K
- Period of performance
- Sep 19, 2024 – Sep 18, 2027
36C24826P1290
Recompete 6–12 mo: Potential end Sep 14, 2027 (10 months away)SYNTHESIS OF NPC86
Department of Veterans Affairs
- Obligated
- $65K
- Period of performance
- Sep 15, 2026 – Sep 14, 2027
75N95024P00489
Recompete 6–12 mo: Potential end Sep 8, 2027 (9 months away)CGMP MITRAGYNINE HCL SUPPLEMENTAL STABILITY & ANALYTICAL ACTIVITIES
Department of Health and Human Services · National Institutes of Health
- Obligated
- $96.2K
- Period of performance
- Sep 9, 2024 – Sep 8, 2027
75N98026P01289
Recompete 6–12 mo: Potential end Aug 13, 2027 (9 months away)NINDS: MEDICINAL CHEMISTRY
Department of Health and Human Services · National Institutes of Health
- Obligated
- $72K
- Period of performance
- Aug 14, 2026 – Aug 13, 2027
HHSN271201800001I-HHSN27100001
Recompete < 6 mo: Potential end Mar 15, 2027 (4 months away)IGF::OT::IGF TASK ORDER NO. 0001 - MEDICINAL CHEMISTRY SUPPORT PROGRAM FOR THERAPEUTIC DEVELOPMENT (MCSP
Department of Health and Human Services · National Institutes of Health
- Obligated
- $173.7K
- Period of performance
- Mar 16, 2018 – Mar 15, 2027
75N95022F00007
Completed: Period of performance ended Apr 14, 2026HIT TO LEAD CHEMISTRY UNDER PERFORMANCE AREA 2 OF ID/IQ CONTRACT NO. HHSN271201800001I
Department of Health and Human Services · National Institutes of Health
- Obligated
- $1.8M
- Period of performance
- Sep 27, 2022 – Apr 14, 2026
75N95022F00003
Completed: Period of performance ended Nov 13, 2025SHAMLOO (STANDFORD UNIVERSITY) - MCSP-EXPLORATORY CHEMISTRY (EC)
Department of Health and Human Services · National Institutes of Health
- Obligated
- $3.4M
- Period of performance
- May 6, 2022 – Nov 13, 2025
75N95019F00064
Completed: Period of performance ended Apr 28, 2025ALBANY MOLECULAR RESEARCH, INC(AMRI)[19-002417]MCSP TASK ORDER XU PROJECT - EXPLORATORY CHEMISTRY POP: TBD
Department of Health and Human Services · National Institutes of Health
- Obligated
- $555.8K
- Period of performance
- Nov 30, 2018 – Apr 28, 2025
75N95024P00611
Completed: Period of performance ended Mar 11, 2025X-RAY CRYSTALLOGRAPHY STUDIES OF ALDH1A2 IN COMPLEX WITH A SMALL MOLECULE INHIBITOR FOR NCATS ETB
Department of Health and Human Services · National Institutes of Health
- Obligated
- $13.3K
- Period of performance
- Sep 12, 2024 – Mar 11, 2025
HHSN271201500005I-HHSN27100001
Completed: Period of performance ended Jan 14, 2025IGF::OT::IGF DRUG MANUFACTURING AND FORMULATION PROGRAM (DMFP) TASK ORDER #01: PERFORMANCE ACTIVITY 1 TECHNICAL SUPPORT (1/15/15 / 1/14/16)
Department of Health and Human Services · National Institutes of Health
- Obligated
- $273.1K
- Period of performance
- Jan 15, 2015 – Jan 14, 2025
HHSN271201500005I-HHSN27100006
Completed: Period of performance ended Sep 24, 2024IGF::OT::IGF DMFP TASK ORDER NO. 6 KENNY BPN 19302
Department of Health and Human Services · National Institutes of Health
- Obligated
- $214.7K
- Period of performance
- Dec 1, 2017 – Sep 24, 2024
75N95022F00005
Completed: Period of performance ended Sep 1, 2024HIT TO LEAD CHEMISTRY UNDER PERFORMANCE AREA 2 OF ID/IQ CONTRACT NO. HHSN271201800001I
Department of Health and Human Services · National Institutes of Health
- Obligated
- $1.5M
- Period of performance
- Jul 27, 2022 – Sep 1, 2024
75N95C24P00010
Completed: Period of performance ended Mar 31, 2024PURIFICATION OF MCHERRY-CNA35 (4L)
Department of Health and Human Services · National Institutes of Health
- Obligated
- $11.3K
- Period of performance
- Feb 8, 2024 – Mar 31, 2024
36C26219C0062
Completed: Period of performance ended Feb 28, 2024PHARMACEUTICALS
Department of Veterans Affairs
- Obligated
- $188.3K
- Period of performance
- Feb 27, 2019 – Feb 28, 2024
HHSN271201500005I-HHSN27100005
Completed: Period of performance ended Jun 29, 2022IGF::OT::IGF DMFP TASK ORDER NO. 5 BUCKPITT BPN 19186
Department of Health and Human Services · National Institutes of Health
- Obligated
- $1.2M
- Period of performance
- Feb 5, 2016 – Jun 29, 2022
75N95020F00004
Completed: Period of performance ended Sep 30, 2021MCSP TORFP NO. NIH-NINDS-20-04: CHILDERS - BASE EC [SUBSTANCE USE DISORDER (COCAINE)]
Department of Health and Human Services · National Institutes of Health
- Obligated
- $631.3K
- Period of performance
- Jun 1, 2020 – Sep 30, 2021
HHSN271201100013C
Completed: Period of performance ended Apr 15, 2019TAS::75 0886::TAS MEDICINAL CHEMISTRY FOR NEUROTHERAPEUTICS PROGRAM (MCNP)
Department of Health and Human Services · National Institutes of Health
- Obligated
- $27.3M
- Period of performance
- Aug 17, 2011 – Apr 15, 2019
| Award | Agency | NAICS · PSC | Obligated | Period of performance | Recompete |
|---|---|---|---|---|---|
75N95024P00615 NON-GMP SYNTHESIS OF COMPOUNDS. POP: 9/19/24-9/18/25. | Department of Health and Human Services · National Institutes of Health | 541380 · Q301REFERENCE LABORATORY TESTING | $884K | Sep 19, 2024 – Sep 18, 2027 | Recompete 6–12 mo: Potential end Sep 18, 2027 (10 months away)AI brief for award 75N95024P00615Bid team for the recompete of award 75N95024P00615 |
36C24826P1290 SYNTHESIS OF NPC86 | Department of Veterans Affairs | 541714 · AJ11GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH | $65K | Sep 15, 2026 – Sep 14, 2027 | Recompete 6–12 mo: Potential end Sep 14, 2027 (10 months away)AI brief for award 36C24826P1290Bid team for the recompete of award 36C24826P1290 |
75N95024P00489 CGMP MITRAGYNINE HCL SUPPLEMENTAL STABILITY & ANALYTICAL ACTIVITIES | Department of Health and Human Services · National Institutes of Health | 541380 · R499SUPPORT- PROFESSIONAL: OTHER | $96.2K | Sep 9, 2024 – Sep 8, 2027 | Recompete 6–12 mo: Potential end Sep 8, 2027 (9 months away)AI brief for award 75N95024P00489Bid team for the recompete of award 75N95024P00489 |
75N98026P01289 NINDS: MEDICINAL CHEMISTRY | Department of Health and Human Services · National Institutes of Health | 541380 · 6505DRUGS AND BIOLOGICALS | $72K | Aug 14, 2026 – Aug 13, 2027 | Recompete 6–12 mo: Potential end Aug 13, 2027 (9 months away)AI brief for award 75N98026P01289Bid team for the recompete of award 75N98026P01289 |
HHSN271201800001I-HHSN27100001 under HHSN271201800001I IGF::OT::IGF TASK ORDER NO. 0001 - MEDICINAL CHEMISTRY SUPPORT PROGRAM FOR THERAPEUTIC DEVELOPMENT (MCSP | Department of Health and Human Services · National Institutes of Health | 541715 · AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | $173.7K | Mar 16, 2018 – Mar 15, 2027 | Recompete < 6 mo: Potential end Mar 15, 2027 (4 months away)AI brief for award HHSN271201800001I-HHSN27100001Bid team for the recompete of award HHSN271201800001I-HHSN27100001 |
75N95022F00007 under HHSN271201800001I HIT TO LEAD CHEMISTRY UNDER PERFORMANCE AREA 2 OF ID/IQ CONTRACT NO. HHSN271201800001I | Department of Health and Human Services · National Institutes of Health | 541715 · AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | $1.8M | Sep 27, 2022 – Apr 14, 2026 | Completed: Period of performance ended Apr 14, 2026 |
75N95022F00003 under HHSN271201800001I SHAMLOO (STANDFORD UNIVERSITY) - MCSP-EXPLORATORY CHEMISTRY (EC) | Department of Health and Human Services · National Institutes of Health | 541715 · AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | $3.4M | May 6, 2022 – Nov 13, 2025 | Completed: Period of performance ended Nov 13, 2025 |
75N95019F00064 under HHSN271201800001I ALBANY MOLECULAR RESEARCH, INC(AMRI)[19-002417]MCSP TASK ORDER XU PROJECT - EXPLORATORY CHEMISTRY POP: TBD | Department of Health and Human Services · National Institutes of Health | 541715 · AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | $555.8K | Nov 30, 2018 – Apr 28, 2025 | Completed: Period of performance ended Apr 28, 2025 |
75N95024P00611 X-RAY CRYSTALLOGRAPHY STUDIES OF ALDH1A2 IN COMPLEX WITH A SMALL MOLECULE INHIBITOR FOR NCATS ETB | Department of Health and Human Services · National Institutes of Health | 541380 · Q301REFERENCE LABORATORY TESTING | $13.3K | Sep 12, 2024 – Mar 11, 2025 | Completed: Period of performance ended Mar 11, 2025 |
HHSN271201500005I-HHSN27100001 under HHSN271201500005I IGF::OT::IGF DRUG MANUFACTURING AND FORMULATION PROGRAM (DMFP) TASK ORDER #01: PERFORMANCE ACTIVITY 1 TECHNICAL SUPPORT (1/15/15 / 1/14/16) | Department of Health and Human Services · National Institutes of Health | 325412 · AZ13R&D- OTHER RESEARCH AND DEVELOPMENT (ADVANCED DEVELOPMENT) | $273.1K | Jan 15, 2015 – Jan 14, 2025 | Completed: Period of performance ended Jan 14, 2025 |
HHSN271201500005I-HHSN27100006 under HHSN271201500005I IGF::OT::IGF DMFP TASK ORDER NO. 6 KENNY BPN 19302 | Department of Health and Human Services · National Institutes of Health | 325412 · AZ13R&D- OTHER RESEARCH AND DEVELOPMENT (ADVANCED DEVELOPMENT) | $214.7K | Dec 1, 2017 – Sep 24, 2024 | Completed: Period of performance ended Sep 24, 2024 |
75N95022F00005 under HHSN271201800001I HIT TO LEAD CHEMISTRY UNDER PERFORMANCE AREA 2 OF ID/IQ CONTRACT NO. HHSN271201800001I | Department of Health and Human Services · National Institutes of Health | 541715 · AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | $1.5M | Jul 27, 2022 – Sep 1, 2024 | Completed: Period of performance ended Sep 1, 2024 |
75N95C24P00010 PURIFICATION OF MCHERRY-CNA35 (4L) | Department of Health and Human Services · National Institutes of Health | 541380 · Q301REFERENCE LABORATORY TESTING | $11.3K | Feb 8, 2024 – Mar 31, 2024 | Completed: Period of performance ended Mar 31, 2024 |
36C26219C0062 PHARMACEUTICALS | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $188.3K | Feb 27, 2019 – Feb 28, 2024 | Completed: Period of performance ended Feb 28, 2024 |
HHSN271201500005I-HHSN27100005 under HHSN271201500005I IGF::OT::IGF DMFP TASK ORDER NO. 5 BUCKPITT BPN 19186 | Department of Health and Human Services · National Institutes of Health | 325412 · AZ13R&D- OTHER RESEARCH AND DEVELOPMENT (ADVANCED DEVELOPMENT) | $1.2M | Feb 5, 2016 – Jun 29, 2022 | Completed: Period of performance ended Jun 29, 2022 |
75N95020F00004 under HHSN271201800001I MCSP TORFP NO. NIH-NINDS-20-04: CHILDERS - BASE EC [SUBSTANCE USE DISORDER (COCAINE)] | Department of Health and Human Services · National Institutes of Health | 541715 · AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | $631.3K | Jun 1, 2020 – Sep 30, 2021 | Completed: Period of performance ended Sep 30, 2021 |
HHSN271201100013C TAS::75 0886::TAS MEDICINAL CHEMISTRY FOR NEUROTHERAPEUTICS PROGRAM (MCNP) | Department of Health and Human Services · National Institutes of Health | 541711 · AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | $27.3M | Aug 17, 2011 – Apr 15, 2019 | Completed: Period of performance ended Apr 15, 2019 |
Contract vehicles
No contract vehicles on file
Proven teaming graph
Primes it has worked under
- THE LELAND STANFORD JUNIOR UNIVERSITY
UEI HJD6G4D6TJY5
$223.5K
Subcontractor to this prime · 3 sub-awards · latest Sep 23, 2026
- National Institutes of Health
- “(FORMAL CONTRACT TITLE: TO DEVELOP SMALL SYNTHETIC CHEMICAL MOLECULES AS BROADLY ACTIVE ANTIVIRAL FOR THE TREATMENT OF VIRAL INFECTIONS) ADVANCING A LEAD BROAD SPECTRUM ANTIVIRAL PI-KINASE INHIBITOR T”
- “"CURIA DESCRIPTION OF WORK NON-GMP MANUFACTURE OF APPROXIMATELY3 KILOGRAM OF STF-2586 AND REPROCESSING AND RETESTING OF STF- 2586 TASK 19: NON-GMP BATCH SUBTASK 19A: BATCH PROCEDURE/RECORD REVIEW AND APPROVAL SUBTASK 19B: MANUFACTURE, RELEASE, STABILITY "”
Subcontractors it has used
No reported sub-awards as a prime contractor.
Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · as of Nov 9, 2026 · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.
SBIR/STTR portfolio
No SBIR/STTR awards on record
Source: SBIR.gov award records (opens in a new tab) · sync date not recorded
FedRAMP offerings
No FedRAMP Marketplace listing
Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded
Exclusions & screening
SAM.gov exclusions
Not yet checked against SAM.gov exclusions.
Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.
Source: SAM.gov Exclusions (opens in a new tab) · sync date not recorded
Consolidated Screening List
No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).
The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.
Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 13, 2026
GSA CALC+ rate benchmark
No GSA CALC+ rates on record
Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded
NAICS, PSC & socio-economic status
NAICS codes
- 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)Primary
- 325199Title not in the curated list
- 325411Title not in the curated list
- 325412Pharmaceutical Preparation Manufacturing
- 325413Title not in the curated list
- 325414Biological Product (except Diagnostic) Manufacturing
- 325998Title not in the curated list
- 541380Testing Laboratories and Services
- 541690Other Scientific and Technical Consulting Services
- 541714Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov does not report this entity as small under any listed NAICS code.
Socio-economic status
No socio-economic certifications reported in SAM.gov.
Product & service codes (PSC)
No PSC codes reported.
Teaming preferences
This company has not published teaming preferences.
Business development contact
No BD contact published
Corporate hierarchy
No parent entity reported in SAM.gov.
SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.
Data sources & provenance
SAM.gov
Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.
USAspending.gov
Prime award history and obligations (FPDS), synced nightly.
The contractor
Nothing yet: this profile has not been claimed by the company.
TeamingIndex verification
Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.
Corrections
Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)
Machine-readable: capability.md schema.org JSON-LD embedded in this page.
Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.
Teaming
Ready to team with CURIA GLOBAL INC?
Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.
